These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8474239)
1. Influence of the timing of blood transfusion on experimental tumor growth. Francis DM; Clunie GJ J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239 [TBL] [Abstract][Full Text] [Related]
2. Soluble and cell-associated forms of some yet to be identified factor in transfused blood which promotes solid tumor growth in mice. Okuyama M; Motoyama S; Saito S; Saito R; Nakamura M; Imano H; Minamiya Y; Ogawa J Surg Today; 2004; 34(8):673-7. PubMed ID: 15290397 [TBL] [Abstract][Full Text] [Related]
3. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Clark DA; Gorczynski RM; Blajchman MA Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of B16 melanoma growth in mice after blood transfusion. Francis DM; Burren CP; Clunie GJ Surgery; 1987 Sep; 102(3):485-92. PubMed ID: 3629476 [TBL] [Abstract][Full Text] [Related]
5. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Younes RN; Rogatko A; Vydelingum NA; Brennan MF Surgery; 1991 Mar; 109(3 Pt 1):307-12. PubMed ID: 2000562 [TBL] [Abstract][Full Text] [Related]
6. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. Da Costa ML; Redmond HP; Bouchier-Hayes DJ J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264 [TBL] [Abstract][Full Text] [Related]
7. Early vaccination with tumor-lysate-pulsed dendritic cells after allogeneic bone marrow transplantation has antitumor effects. Moyer JS; Maine G; Mulé JJ Biol Blood Marrow Transplant; 2006 Oct; 12(10):1010-9. PubMed ID: 17084367 [TBL] [Abstract][Full Text] [Related]
8. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041 [TBL] [Abstract][Full Text] [Related]
9. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma. Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101 [TBL] [Abstract][Full Text] [Related]
10. Is immunosuppression at the tumor site mechanism of evasion of a systemic response? Karakousis CP; Sharma S; Brooks SP J Med; 2003; 34(1-6):3-14. PubMed ID: 17682306 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic cell therapy for a murine mammary carcinoma. Morecki S; Yacovlev E; Diab A; Slavin S Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499 [TBL] [Abstract][Full Text] [Related]
13. Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue. Drewa G; Woźqak A; Pałgan K; Schachtschabel DO; Grzanka A; Sujkowska R Neoplasma; 2001; 48(1):12-8. PubMed ID: 11327532 [TBL] [Abstract][Full Text] [Related]
14. [Effect of histamine on metastasis of melanoma B16 cell xenograft in C57BL/6 mice]. Qin YS; Zhang X; Li L; Yu HL Ai Zheng; 2007 Aug; 26(8):833-6. PubMed ID: 17697542 [TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor effect through human endostatin gene transfer in mice bearing B16 melanoma]. Zhang B; Zou W; Wu G; Jin D; Xu D; Zheng Z; Wu Z; Liu X Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):451-4. PubMed ID: 12485496 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962 [TBL] [Abstract][Full Text] [Related]
17. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. Yoshida R; Yoneda Y; Kuriyama M; Kubota T J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111 [TBL] [Abstract][Full Text] [Related]
18. [Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth--experimental studies in rats]. Scholler PM; Zeller WJ; Rössler W; Lenhard V; Weber E; Schmähl D; Dreikorn K Arch Geschwulstforsch; 1987; 57(2):81-90. PubMed ID: 3592925 [TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity. Melcher A; Todryk S; Bateman A; Chong H; Lemoine NR; Vile RG Cancer Res; 1999 Jun; 59(12):2802-5. PubMed ID: 10383135 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]